Blue Jet Healthcare Ltd Stock Falls to 52-Week Low of Rs.402.65

Recent Price Movement and Market Context

On 2 Feb 2026, Blue Jet Healthcare Ltd (Stock ID: 10039056) recorded its lowest price in the past year at Rs.402.65, representing a significant drop from its 52-week high of Rs.1,028.20. The stock has been on a losing streak for three consecutive days, shedding approximately 3.37% over this period. Despite this decline, it marginally outperformed its Pharmaceuticals & Biotechnology sector by 0.59% on the day.

Meanwhile, the broader market showed resilience with the Sensex recovering sharply from an initial negative opening. The benchmark index closed at 81,006.97, up 0.35%, supported by gains in mega-cap stocks. However, Blue Jet Healthcare’s share price remains below all key moving averages – 5-day, 20-day, 50-day, 100-day, and 200-day – signalling sustained downward pressure.

Performance Overview and Valuation Metrics

Over the last twelve months, Blue Jet Healthcare has delivered a total return of -46.45%, markedly underperforming the Sensex’s 4.46% gain during the same period. The stock’s valuation reflects a Price to Book Value ratio of 5.7, which is considered expensive relative to its peers. This elevated valuation contrasts with the company’s current market cap grade of 3 and a Mojo Score of 46.0, which corresponds to a Sell rating as of 6 Jan 2026, downgraded from Hold.

Despite the recent price weakness, the company maintains a strong Return on Equity (ROE) of 28.1%, indicative of efficient capital utilisation. However, the Price/Earnings to Growth (PEG) ratio stands at a low 0.2, reflecting a disconnect between valuation and earnings growth expectations.

Financial Results and Operational Indicators

The company’s quarterly profit after tax (PAT) for the September 2025 quarter stood at Rs.52.14 crores, reflecting a decline of 41.8% compared to the previous four-quarter average. This flat performance has contributed to the recent negative sentiment surrounding the stock.

Operating cash flow for the year was reported at Rs.45.76 crores, marking the lowest level recorded in recent periods. Additionally, the debtors turnover ratio for the half-year was 0.38 times, indicating slower collection efficiency relative to historical norms.

These financial metrics highlight areas where the company’s near-term performance has softened, despite its historically strong fundamentals.

Long-Term Growth and Capital Structure

Blue Jet Healthcare exhibits robust long-term growth characteristics, with net sales expanding at an annualised rate of 25.62% and operating profit growing at 38.55% per annum. The company’s average Return on Equity over the long term is a healthy 23.50%, underscoring consistent profitability.

Capital structure remains conservative, with an average debt-to-equity ratio of zero, reflecting a debt-free balance sheet. Promoters continue to hold a majority stake, maintaining significant control over the company’s strategic direction.

Comparative Performance and Market Position

Despite the company’s strong fundamentals, Blue Jet Healthcare has underperformed not only the Sensex but also the broader BSE500 index over multiple time frames, including the last three years, one year, and three months. This underperformance is reflected in the stock’s current Mojo Grade of Sell, downgraded from Hold earlier this year.

The stock’s discount to peer valuations suggests that the market is pricing in the recent earnings softness and valuation concerns, contributing to the sustained price weakness.

Summary of Key Metrics

To summarise, Blue Jet Healthcare Ltd’s stock has reached a 52-week low of Rs.402.65 after a sustained period of price decline. The company’s recent quarterly earnings showed a notable contraction in PAT, while operating cash flows and debtor efficiency have also weakened. Despite these short-term pressures, the firm maintains strong long-term growth rates, a solid ROE, and a debt-free capital structure.

The stock’s valuation remains elevated relative to peers, which, combined with recent earnings softness, has contributed to its current Mojo Grade of Sell. The share price continues to trade below all major moving averages, reflecting ongoing market caution.

Overall, Blue Jet Healthcare’s recent price action and financial indicators illustrate a complex picture of near-term challenges set against a backdrop of solid fundamental strength.

Upgrade at special rates, valid only for the next few days. Claim Your Special Rate →